>
pdufa.bio

Tanruprubart

Updated ยทnext FDA decision on the calendar

Tanruprubart is a Annexon, Inc. program. Its next catalyst is a Readout in Oct 2026. Every date links its source.

ANNX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Annexon, Inc. (ANNX). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Oct 2026ANNX

Questions

When is Tanruprubart's next FDA decision or readout?

The next tracked catalyst for Tanruprubart is a Readout in Oct 2026.

What happened at Tanruprubart's most recent FDA decision?

No FDA decision for Tanruprubart is in our archive yet.

Who makes Tanruprubart?

Annexon, Inc. (ANNX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.